ESC 365 - Long-term safety of stereotactic body radiotherapy for ablation of ventricular tachycardia: a multicentric study

ESC Premium Access

Long-term safety of stereotactic body radiotherapy for ablation of ventricular tachycardia: a multicentric study

Session: The substrate for ventricular arrhythmia - From ECG to non-invasive therapy

Topic: Clinical

Speaker: Mr J. Cvek (Ostrava, CZ)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Mr Jakub Cvek

University Hospital Ostrava, Ostrava (Czechia)

0 follower

4 more presentations in this session

State of the Art - Imaging for substrate identification in ventricular arrhythmia

Speaker: Professor P. Jais (Bordeaux, FR)

Manifestations of myocardial fibrosis in the standard 12-lead electrocardiogram

Speaker: Mr L. Holmstrom (Oulu, FI)

Characterization of the arrhythmogenic substrate with multimodality imaging in ischemic patients undergoing VT ablation: relationship between cardiac computed tomography and magnetic resonance

Speaker: Doctor G. Zucchelli (Pisa, IT)

Non-invasive therapy for ventricular arrhythmia.

Speaker: Doctor D. Packer (Salt Lake City, US)

Access the full session

The substrate for ventricular arrhythmia - From ECG to non-invasive therapy

Speakers: Mr J. Cvek, Professor P. Jais, Mr L. Holmstrom, Doctor G. Zucchelli, Doctor D. Packer

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources